Skip to content

A Study on the Neurobiological Mechanisms of Chinese Acupuncture-Electrotherapy Combined with Psychotherapy in Intervening Subthreshold Depression in Adolescents

A Study on the Neurobiological Mechanisms of Chinese Acupuncture-Electrotherapy Combined with Psychotherapy in Intervening Subthreshold Depression in Adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001465
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subthreshold depression

Interventions

Electroacupuncture Group Combined with Psychological Therapy Group:Electroacupuncture group combined with psychotherapy
The micro-electroacupuncture group combined with the psychotherapy group.:Micro-electro acupuncture group combined with psychological therapy
Psychotherapy Team:Psychotherapy

Sponsors

Shenzhen City Luohu District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years

Inclusion criteria

Inclusion criteria: Experimental group: (1) Age: 13–18 years; (2) Meeting the clinical diagnostic criteria for subthreshold depression, with a HAMD-7 score between 7 and 17; (3) First-episode, drug-naïve patients, or no history of antidepressant treatment within the past year; (4) Right-handed; (5) Signed informed consent obtained from guardians and the participant. Healthy control group: (1) Age: 13–18 years; (2) Right-handed; (3) No current or past history of psychiatric disorders based on detailed evaluation, Patient Health Questionnaire-9 (PHQ-9) total score < 5, and all item scores = 1; (4) Snaith-Hamilton Pleasure Scale (SHAPS) total score within the normal range, with no significant anhedonia; (5) Signed informed consent obtained from guardians and the participant.

Exclusion criteria

Exclusion criteria: Experimental Group: (1) Any history of psychiatric disorders; (2) History of neurological diseases or brain injury; (3) History of major or chronic physical illnesses that have received systematic treatment; (4) Use of psychotropic medications (e.g., antidepressants, anxiolytics, sedative-hypnotics) within the recent 3 months prior to enrollment; (5) Any contraindication to MRI scanning (e.g., metal implants in the body, pacemaker, claustrophobia, etc.); (6) Intellectual disability (assessed by school performance or clinical impression; individuals suspected of intellectual impairment must undergo the Wechsler Intelligence Scale, and those with IQ < 80 are excluded); (7) Any other factor that, in the investigator's judgment, makes the individual unsuitable for the study. Healthy Control Group: (1) History of psychiatric disorders or family history, including but not limited to depressive disorder, anxiety disorder, obsessive-compulsive disorder, schizophrenia, substance use disorder, etc.; presence of any clinically significant psychological symptoms; or a first-degree relative (parents, full siblings) with a confirmed family history of psychiatric disorders (especially mood disorders);(2) Neurological and physical illnesses: a definite history of neurological diseases (e.g., epilepsy, traumatic brain injury with loss of consciousness, encephalitis, etc.); serious or unstable physical illnesses (e.g., endocrine diseases, autoimmune diseases, cardiovascular diseases, hepatic or renal insufficiency, etc.); (3) Any contraindication to MRI scanning; (4) Medication use: long-term use of any psychotropic medications within the recent 3 months prior to enrollment; history of substance abuse or dependence (including alcohol, tobacco, illicit drugs); (5) Other factors: intellectual disability (individuals with IQ < 80 are excluded); (6) Experience of a major negative life event within the recent 6 months prior to enrollment (e.g., death of a loved one, parental divorce, etc.) that caused severe psychological impact; (7) Any other factor that, in the investigator's judgment, makes the individual unsuitable for the study. Individuals meeting any of the above criteria are not eligible for enrollment.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale;MRI Data;

Secondary

MeasureTime frame
Hamilton Anxiety Scale;Pittsburgh Sleep Quality Index;

Countries

China

Contacts

Public ContactYu Xin

Shenzhen City Luohu District Traditional Chinese Medicine Hospital

yusanjin1995@sina.com+86 19801201450

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026